These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 12193103

  • 21. Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise.
    Maeda S, Miyauchi T, Iemitsu M, Tanabe T, Goto K, Yamaguchi I, Matsuda M.
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E609-14. PubMed ID: 14665447
    [Abstract] [Full Text] [Related]

  • 22. [Effect of tashinone on nitric oxide synthase in hypertrophic cardiomyocyte of rats suffered abdominal aorta constriction].
    Li YS, Wang ZH, Yan L, Yong YQ, Wang J, Liang QS, Zheng Z, Yang GT.
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1446-50. PubMed ID: 18837353
    [Abstract] [Full Text] [Related]

  • 23. Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism.
    Wolf SC, Sauter G, Rodemann HP, Risler T, Brehm BR.
    Nephrol Dial Transplant; 2005 Feb; 20(2):312-8. PubMed ID: 15585510
    [Abstract] [Full Text] [Related]

  • 24. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
    Brochu E, Lacasse S, Moreau C, Lebel M, Kingma I, Grose JH, Larivière R.
    Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266
    [Abstract] [Full Text] [Related]

  • 25. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
    Jesmin S, Zaedi S, Yamaguchi N, Maeda S, Shimojo N, Masuzawa K, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):902-6. PubMed ID: 16741021
    [Abstract] [Full Text] [Related]

  • 26. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.
    Zatta AJ, Kin H, Lee G, Wang N, Jiang R, Lust R, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Vinten-Johansen J.
    Cardiovasc Res; 2006 May 01; 70(2):315-24. PubMed ID: 16443207
    [Abstract] [Full Text] [Related]

  • 27. Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats.
    Jesmin S, Zaedi S, Yamaguchi N, Maeda S, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 01; 231(6):1034-9. PubMed ID: 16741044
    [Abstract] [Full Text] [Related]

  • 28. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ.
    Clin Exp Pharmacol Physiol; 2009 Mar 01; 36(3):312-8. PubMed ID: 18986329
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Discovery and synthesis of (S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic acid (LU 302872), a novel orally active mixed ET(A)/ET(B) receptor antagonist.
    Amberg W, Hergenröder S, Hillen H, Jansen R, Kettschau G, Kling A, Klinge D, Raschack M, Riechers H, Unger L.
    J Med Chem; 1999 Aug 12; 42(16):3026-32. PubMed ID: 10447946
    [Abstract] [Full Text] [Related]

  • 32. Chronic exposure to ammonia induces isoform-selective alterations in the intracellular distribution and NMDA receptor-mediated translocation of protein kinase C in cerebellar neurons in culture.
    Giordano G, Sanchez-Perez AM, Burgal M, Montoliu C, Costa LG, Felipo V.
    J Neurochem; 2005 Jan 12; 92(1):143-57. PubMed ID: 15606904
    [Abstract] [Full Text] [Related]

  • 33. CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats.
    He HB, Dai DZ, Dai Y.
    Acta Pharmacol Sin; 2006 Sep 12; 27(9):1213-21. PubMed ID: 16923343
    [Abstract] [Full Text] [Related]

  • 34. Remodeling of resistance arteries in renal failure: effect of endothelin receptor blockade.
    Amann K, Mil Tenberger-Mil Tenyi G, Simonoviciene A, Koch A, Orth S, Ritz E.
    J Am Soc Nephrol; 2001 Oct 12; 12(10):2040-2050. PubMed ID: 11562402
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.